EP2265246A1 - Zubereitungen zur verringerung von juckreiz und anderen missempfindungen mit (1 r,2s,5r)-isopropyl-5-methyl-n(2-(pyridin-2yl)ethyl- cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2- isopropyl-5-methylcyclohexancarboxamid - Google Patents
Zubereitungen zur verringerung von juckreiz und anderen missempfindungen mit (1 r,2s,5r)-isopropyl-5-methyl-n(2-(pyridin-2yl)ethyl- cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2- isopropyl-5-methylcyclohexancarboxamidInfo
- Publication number
- EP2265246A1 EP2265246A1 EP09731688A EP09731688A EP2265246A1 EP 2265246 A1 EP2265246 A1 EP 2265246A1 EP 09731688 A EP09731688 A EP 09731688A EP 09731688 A EP09731688 A EP 09731688A EP 2265246 A1 EP2265246 A1 EP 2265246A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- isopropyl
- preparations
- cyanomethyl
- carboxamide
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/004—Aftersun preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Definitions
- the present invention relates to cosmetic and dermatological preparations for reducing dermatological discomfort.
- the skin of older people which is also referred to as aging skin, differs significantly from young skin.
- the moisture and fat content sinks, the skin dries up and begins to stretch and itch. Itchy skin can also be caused by UV radiation.
- a slight sunburn manifests itself here also by dermatological abnormal sensations, such as feeling of tension, redness, hypersensitivity and itching.
- Itching is an independent sensation of the skin and arises independently of the pain sensation.
- the superficial nerve endings in the skin react to many different chemical messengers from the skin and the blood with the development of itching.
- the various messenger substances explain the various itching sensations such as itching, stinging or burning itching, aching tingling, etc.
- the itching sensation is transported via the nerves of the spinal cord to the brain, where the desire for scratching is immediately triggered.
- barrier-strengthening agents e.g. Omrga-6 fatty acids from natural evening primrose oil.
- cooling substances examples include menthol, menthone, ethyl menthane carboxamido acetate (WS-5), isopulegol (Coolact P), menthanediol (Coolact 38D), N, 2,3-trimethyl-2-isopropylbutanamide (WS-23), Ethyl menthane carboxamide (WS-3), menthone glycerine acetal (Frescolat MGA) or mono-menthyl succinate (Physcool).
- the preparations are easy to formulate and do not place great demands on manufacturing processes.
- the cooling substances are pre-dissolved in polyols and added at about 40 0 C of the emulsion.
- menthoxypropanediol is additionally present.
- the preparations contain from 0.001 to 10% by weight, particularly preferably from 0.01 to 1% by weight, of (1R, 2S, 5R) -2-isopropyl-5-methyl-N- (2 - (pyridin-2-yl) ethylcyclohexanecarboxamide and / or (1R, 2S, 5R) -N- (4- (cyanomethyl) phenyl) -2-isopropyl-5-methylcyclohexancarboxam ⁇ d contain, based on the total composition of the preparations.
- the preparations contain from 0.001 to 10% by weight, particularly preferably 0.01 to 1% by weight, of menthoxypropanediol, based on the total composition of the preparations. It is preferred if the preparations contain light stabilizers if the preparations contain antioxidants. It is further preferred if the preparations contain vitamins
- the cosmetic and dermatological preparations according to the invention are applied to the skin and / or the hair in a sufficient amount in the manner customary for cosmetics
- the cosmetic and dermatological preparations according to the invention may contain cosmetic adjuvants such as are conventionally used in such preparations, for example preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments which have a coloring effect, thickeners, wetting and / or moisturizing substances, fats, oils, waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, thickeners, sunscreen filters, fillers, foam stabilizers, electrolytes, organic solvents or Silikondenvate.
- cosmetic adjuvants such as are conventionally used in such preparations, for example preservatives, bactericides, perfumes, substances for preventing foaming, dyes, pigments which have a coloring effect, thickeners, wetting and / or moisturizing substances, fats, oils, waxes or other common ingredients of a cosmetic or dermatological formulation such as alcohols, polyols, polymers, thickeners, sunscreen filters, fillers, foam stabilizer
- antioxidants which are suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants
- the amount of the aforementioned antioxidants (one or more compounds) in the preparations is preferably 0.001 to 30 wt .-%, particularly preferably 0.05 to 20 wt .-%, in particular 0 5 to 10 wt -%, based on the total weight of preparation
- the cosmetic or dermatological preparation in the sense of the present invention is a solution or emulsion or dispersion, it can be used as solvent
- Water or aqueous solutions oils such as synthetic triglycerides of capric or caprylic acid, alkyl benzoates or other fatty acid esters or vegetable oils, such as sunflower oil, evening primrose oil, grape seed oil, apricot kernel, argan oil or almond oil.
- Fats, waxes and other natural and synthetic Fettkorper preferably esters of fatty acids with alcohols of low carbon number, for example with isopropanol, propylene glycol or Glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids,
- Alcohols, diols or polyols of low C number, and their ethers preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, pectanediol, wieihyipropan ⁇ ioi, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and analog products.
- mixtures of the abovementioned solvents are used.
- alcoholic solvents water can be another ingredient
- the oil phase of erfindu ⁇ gswash preferred preparations is advantageously selected from the group of esters of saturated and / or unsaturated, branched and / or unbranched alkanecarboxylic acids having a chain length of 3 to 30 carbon atoms and saturated and / or unsaturated, branched and / or unbranched alcohols Chain length of 3 to 30 carbon atoms, from the group of esters of aromatic carboxylic acids and saturated and / or unsaturated, branched and / or unbranched alcohols having a chain length of 3 to 30 carbon atoms.
- ester oils may, for example, advantageously be selected from the group isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laurate, n-decyl oleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate , 2-Octyldodecylpalm ⁇ tat, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate and synthetic, semi-synthetic and natural mixtures of such esters, for example jojoba oil
- the oil phase can advantageously be selected from the group of branched and unbranched hydrocarbons and waxes, silicone oils, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also the fatty acid triglycerides, in particular the saturated and unsaturated glycerol esters or unsaturated, branched and / or unbranched alkanecarboxylic acids of a chain length of 8 to 24, in particular 12 to 18 carbon atoms.
- the fatty acid triglycerides can be selected, for example, advantageously from the group of synthetic, semisynthetic and natural oils, for example Olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, almond oil, palm oil, coconut oil, palm kernel oil, and the like
- Advantageous preservatives for the purposes of the present invention are, for example, benzyl alcohol, sorbic acid and its salts, formaldehyde releasers (such as diazolidinyl urea (trade name Germall II of ISP), imidazolidinyl urea (trade name Germall 115) or DMDM Hydantoi ⁇ , which is available, for example, under the trade name Glydant TM available from Lonza), methylisothiazolinone and corresponding derivatives (trade name Kathon CG), iodopropynyl butyl carbamates (for example, those available under the trade names Glycacil-L, Glycacil-S from Lonza and / or Dekaben LMB of Jan Dekker), parabens (ie, p-hydroxybenzoic acid alkyl esters such as methyl, ethyl, propyl
- formaldehyde releasers such as diazolidinyl ure
- the preservative system according to the invention furthermore advantageously also comprises substances which improve the effectiveness of conventional preservatives, for example hexanediol, pentanediol, butylene glycol and methylpropanediol.
- Suitable propellants for sprayable from aerosol containers cosmetic and / or dermatological preparations in the context of the present invention the usual known volatile, liquefied propellants, such as hydrocarbons (propane, butane, isobutane) are suitable, which can be used alone or in mixture with each other. Also, compressed air is advantageous to use.
- hydrocarbons propane, butane, isobutane
- Cosmetic preparations in the context of the present invention may also be present as gels which, in addition to an effective content of the active ingredient according to the invention and solvents customarily used for this purpose, preferably water, also contain organic thickeners.
- Gel formers also known as thickeners, are macromolecules which have a largely linear shape and intermolecular interaction forces that allow side and Hauptvalenzitatien between the individual molecules and thus the formation of a net-like structure. They include partially water-soluble natural or synthetic polymers that form gels or viscous solutions in aqueous systems. They increase the viscosity of the water either by binding water molecules (hydration) or by taking up and enveloping the water in their interwoven macromolecules. at the same time restricting the mobility of the water.
- Such water-soluble polymers represent a large group of chemically very different natural and synthetic polymers whose common feature is their solubility in water or aqueous media. The prerequisite for this is that these polymers have a sufficient number of hydrophilic groups for the water-solubility and are not too strongly crosslinked.
- the hydrophilic groups may be nonionic, anionic or cationic in nature.
- Advantageous thickeners for cosmetic preparations are, for example, copolymers of C 1o- o-o-alkyl acrylates and one or more monomers of acrylic acid, methacrylic acid or their esters.
- the INCI name for such compounds is "Acrylates / C 10-30 Alkyl Acrylate Crosspolymer.”
- Particularly advantageous are the Pemulen® types TR 1, TR 2 and TRZ from Goodrich (Noveon).
- Carbopols are also advantageous gelling agents for preparations according to the invention.
- Carbopols are polymers of acrylic acid, especially acrylate-alkyl acrylate copolymers.
- advantageous carbopols are the types 980, 981, 984 1342, 1382, 2984 and 5984, as well as the ETD types 2001, 2020, 2050 and Carbopol Ultrez 10, PVM / MA decadiene crosspolymer (trade name Stabileze 06), polyglyceryl methacrylate and polyacrylamide.
- gelling agents for such preparations are xanthan gum, polyvinylpyrrolidone, cellulose derivatives, in particular cellulose ethers such as, for example, hydroxypropylmethylcellulose, starch and starch derivatives, hyaluronic acid locust bean gum, silicon dioxide and aluminum silicates.
- the thickening agent is present in the gel, dispersion or emulsion e.g. in an amount of between about 0.01 and 5% by weight, preferably between about 0.1 and 2% by weight.
- acrylamidomethylpropyl sulfonic acid polymers in short AMPS polymers, may be commercially available as 100% active substance or as inverse thickener. Examples:
- Aristoflex AVC (ammonium acryloyldimethyltaurate / VP Copolymer, Clariant)
- Aristoflex HMB (ammonium acryloyldimethyltaurate / beheneth-25 methacrylate copolymer, Clariant)
- Simulgel NS (Seppic): hydroxyethyl acrylate / sodium acryloyldimethyl taurate copolymer / squalane / polysorbate
- acrylamidomethylpropylsulfonic polymers carry the INCI name Ammoniunnacryloyldimethyltaurat / vinylpyrrolidinone copolymers.
- Complexing agents are known auxiliaries of cosmetology and medical galenics. Complexing agents, in particular chelators, form complexes with metal atoms, which in the presence of one or more polybasic complexing agents, ie chelators, represent metallacycles. Chelates are compounds in which a single ligand occupies more than one coordination site on a central atom. In this case, normally stretched compounds are closed by complexing a metal atom or ion into rings. The number of bound ligands depends on the coordination number of the central metal. The prerequisite for chelation is that the metal-reactive compound contain two or more atomic groups acting as electron donors.
- the complexing agent (s) can advantageously be selected from the group of conventional compounds, preferably at least one of tartaric acid and its a ⁇ ions, citric acid and its anions, aminopolycarboxylic acids and their anions (such as ethylenediaminetetraacetic acid (EDTA) and their anions, and nitrilotriacetic acid (NTA) and their anions is selected.
- EDTA ethylenediaminetetraacetic acid
- NTA nitrilotriacetic acid
- the complexing agent (s) according to the invention are advantageously present in cosmetic or dermatological preparations generally at from about 0.01% by weight to about 10% by weight, preferably from about 0.05% by weight to about 10% by weight, more preferably at about 0.1-1.0% by weight, based on the total weight of the preparations.
- composition according to the invention should be present in a form suitable for topical application.
- the composition may be in the form of a cream, a lotion, a gel, an ointment, a tincture, a skin oil, a milk, a balm, a composition impregnated plaster, a fabric impregnated with the composition, a fabric impregnated with the composition, a composition-impregnated pad, spray, aerosol, roll-on, stick, soft solid, powder or powder spray
- the formulations according to the invention may furthermore contain substances which absorb UV radiation in the UVB range, the total amount of filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
- the total amount of filter substances being, for example, 0.1% by weight to 30% by weight, preferably 0.5 to 10% by weight, in particular 1 to 6% by weight, based on the total weight of the preparations.
- Formulation example 2 Rich cream for dry skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008015425A DE102008015425A1 (de) | 2008-03-20 | 2008-03-20 | Kosmetische oder dermatologische Zubereitungen zur Verringerung von Juckreiz und anderen dermatologischen Missempfindungen, die insbesondere bei Altershaut auftreten können, mit einem Gehalt an (1R,2S,5R)-2-Isopropyl-5-methyl-N-(2-(pyridin-2-yl)ethyl-cyclohexancarboxamid und/oder (1R,2S,5R)-N-(4-(Cyanomethyl)-phenyl)-2-isopropyl-5-methylcyclohexancarboxamid |
PCT/EP2009/000687 WO2009127282A1 (de) | 2008-03-20 | 2009-02-03 | Zubereitungen zur verringerung von juckreiz und anderen missempfindungen mit (1 r,2s,5r)-isopropyl-5-methyl-n(2-(pyridin-2yl)ethyl- cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2- isopropyl-5-methylcyclohexancarboxamid |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2265246A1 true EP2265246A1 (de) | 2010-12-29 |
Family
ID=40942384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09731688A Withdrawn EP2265246A1 (de) | 2008-03-20 | 2009-02-03 | Zubereitungen zur verringerung von juckreiz und anderen missempfindungen mit (1 r,2s,5r)-isopropyl-5-methyl-n(2-(pyridin-2yl)ethyl- cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2- isopropyl-5-methylcyclohexancarboxamid |
Country Status (4)
Country | Link |
---|---|
US (1) | US20120039823A1 (de) |
EP (1) | EP2265246A1 (de) |
DE (1) | DE102008015425A1 (de) |
WO (1) | WO2009127282A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2368972B1 (de) * | 2010-03-23 | 2013-05-15 | Cognis IP Management GmbH | Hautfreundliche Handgeschirrspülmittel |
DE102012218733A1 (de) * | 2012-10-15 | 2014-04-17 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitung zur Prophylaxe und/oder Behandlung atopischer Dermatitis |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4459425A (en) * | 1981-11-20 | 1984-07-10 | Takasago Perfumery Co., Ltd. | 3-Levo-Menthoxypropane-1,2-diol |
WO2000062737A1 (en) * | 1999-04-16 | 2000-10-26 | Unilever Plc | Cosmetic composition |
US20030235545A1 (en) * | 2002-06-24 | 2003-12-25 | Eric Guenin | Cool and dry soft solid antiperspirant |
EP1430880A2 (de) * | 2002-12-20 | 2004-06-23 | Hans Schwarzkopf & Henkel GmbH & Co. KG | Alkoholfreie Deosprays mit hautkühlenden Wirkstoffen |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1006572B (it) * | 1972-04-18 | 1976-10-20 | Wilkinson Sword Ltd | Composizioni ingeribili locali e altre aventi un effetto fisiologi co raffreddante sulla pelle e sul le membrane mucose del corpo |
GB1422998A (en) * | 1973-03-22 | 1976-01-28 | Wilkinson Sword Ltd | Cyclohexanecarboxamides having a physiological cooling effect and compositions containing them |
FR2789390B3 (fr) * | 1999-02-10 | 2001-03-09 | Sanofi Sa | Nouveaux derives de piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant |
DE10029462A1 (de) | 2000-06-21 | 2002-01-03 | Clariant Gmbh | Wasserlösliche Polymere und ihre Verwendung in kosmetischen und pharmazeutischen Mitteln |
DE60313515T2 (de) * | 2003-11-12 | 2008-01-03 | Symrise Gmbh & Co. Kg | Mischung mit wintergrün-geruch und geschmack |
DE602004026619D1 (en) * | 2003-11-21 | 2010-05-27 | Givaudan Sa | N-substituierte p-menthancarbonsäureamide |
US20050187211A1 (en) * | 2004-02-23 | 2005-08-25 | Wei Edward T. | N-arylsalkyl-carboxamide compositions and methods |
CN101257949B (zh) * | 2005-08-15 | 2011-01-19 | 奇华顿股份有限公司 | 清凉化合物 |
EP1948236B1 (de) * | 2005-09-27 | 2021-03-03 | Special Water Patents B.V. | Methoden und zusammensetzungen zur behandlung der haut |
US20070190190A1 (en) * | 2006-02-14 | 2007-08-16 | Ramirez Jose E | Conditioning compositions and methods of use thereof |
-
2008
- 2008-03-20 DE DE102008015425A patent/DE102008015425A1/de not_active Withdrawn
-
2009
- 2009-02-03 EP EP09731688A patent/EP2265246A1/de not_active Withdrawn
- 2009-02-03 US US12/933,231 patent/US20120039823A1/en not_active Abandoned
- 2009-02-03 WO PCT/EP2009/000687 patent/WO2009127282A1/de active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4459425A (en) * | 1981-11-20 | 1984-07-10 | Takasago Perfumery Co., Ltd. | 3-Levo-Menthoxypropane-1,2-diol |
WO2000062737A1 (en) * | 1999-04-16 | 2000-10-26 | Unilever Plc | Cosmetic composition |
US20030235545A1 (en) * | 2002-06-24 | 2003-12-25 | Eric Guenin | Cool and dry soft solid antiperspirant |
EP1430880A2 (de) * | 2002-12-20 | 2004-06-23 | Hans Schwarzkopf & Henkel GmbH & Co. KG | Alkoholfreie Deosprays mit hautkühlenden Wirkstoffen |
Non-Patent Citations (1)
Title |
---|
See also references of WO2009127282A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE102008015425A1 (de) | 2010-01-21 |
WO2009127282A1 (de) | 2009-10-22 |
US20120039823A1 (en) | 2012-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT503467B1 (de) | Fett(öl)haltiges mittel, enthaltend zwiebelextrakt, seine herstellung und seine verwendung zur pflege, vorbeugung oder behandlung von geschädigtem hautgewebe, insbesondere von narben | |
EP2265245B1 (de) | Kühlende kosmetische oder dermatologische zubereitungen mit einem gehalt an (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexancarboxamid zu reduktion von hautrötungen | |
EP3082752B1 (de) | Verwendung von alkylamidothiazolen in kosmetischen oder dermatologischen zubereitungen zur prophylaxe vor und behandlung von sensibler haut | |
EP1294351A1 (de) | Verwendung von calcium freisetzenden oder bindenden substanzen zur gezielten schwächung oder stärkung der barrierefunktion der haut | |
DE102012218733A1 (de) | Kosmetische oder dermatologische Zubereitung zur Prophylaxe und/oder Behandlung atopischer Dermatitis | |
EP2265243A2 (de) | Kühlende kosmetische oder dermatologische zubereitungen mit einem gehalt an (1r,2s,5r)-2-isopropyl-5-methyl-n-(2-(pyridyn-2-yl)ethyl-cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)phenyl)-2-isopropyl-5- methylcyclohexancarboxamid mit menthoxypropandiol | |
EP2654699B1 (de) | Wirkstoffkombinationen aus glucosylglyceriden und einem oder mehreren konservierungsmitteln | |
EP1885329B1 (de) | Kosmetische zubereitungen mit einem gehalt an glucosylglyceriden und einem acrylamidomethylpropylsulfonsäure-vp-copolymer | |
EP1885328B1 (de) | Wirkstoffkombinationen aus glucosylglyceriden und kreatin und/oder kreatinin | |
DE102005029387B4 (de) | Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyglyceryl(3)-Methylglucosedistearat | |
EP2265246A1 (de) | Zubereitungen zur verringerung von juckreiz und anderen missempfindungen mit (1 r,2s,5r)-isopropyl-5-methyl-n(2-(pyridin-2yl)ethyl- cyclohexancarboxamid und/oder (1r,2s,5r)-n-(4-(cyanomethyl)-phenyl)-2- isopropyl-5-methylcyclohexancarboxamid | |
DE102014104257A1 (de) | Wirkstoffkombinationen aus Ethylhexyl-2-cyano-3,3-diphenylacrylat und 4-Hydroxyacetophenon sowie kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombinationen enthaltend | |
DE102005023640A1 (de) | Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure | |
EP2090290B1 (de) | Verwendung von 3-(4-Hydroxy-3-methoxphenyl)-1-(4-hydroxyphenyl)-propan-1-on zur verbesserten Hautkonturierung bzw. gegen Cellulite | |
DE102005029388B4 (de) | Wirkstoffkombinationen aus Glycopyrroniumbromid und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und/oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure | |
WO2010121676A2 (de) | Verwendung von glycyrrhetinsäure und/oder deren derivaten zur herstellung kosmetischer oder dermatologischer zubereitungen zur prophylaxe von schäden an der hauteigenen dna und/oder zur reparatur bereits eingetretener schäden an der hauteigenen dna | |
EP2076240B1 (de) | Kosmetische oder dermatologische zubereitungen mit einem gehalt an 2-isopropyl-5- methyl-cyclohexancarbonyl-d-alaninmethylester und einem oder mehreren anti-entzündlichen wirkstoffen | |
EP2086499B1 (de) | Kosmetische oder dermatologische zubereitungen mit einem gehalt an 2-isopropyl-5- methyl-cyclohexancarbonyl-d-alaninmethylester und einem oder mehreren hautbefeuchtungsmitteln | |
EP2745832B1 (de) | Hautpflegemittel zur Behandlung reifer Haut | |
DE102006047154A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren anti-entzündlichen Wirkstoffen | |
DE102006047166A1 (de) | Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an 2-Isopropyl-5-Methyl-Cyclohexancarbonyl-D-Alaninethylester und einem oder mehreren Hautbefeuchtungsmitteln | |
EP2216012A2 (de) | Wärmende kosmetische oder dermatologische Zubereitung | |
WO2016034400A1 (de) | Verwendung von gossypetin und/oder gossypin gegen hautalterung | |
DE102014104254A1 (de) | Wirkstoffkombinationen aus 4-Hydroxyacetophenon und einem oder mehreren Zimtsäurederivaten, sowie kosmetische oder dermatologische Zubereitungen, diese Wirkstoffkombinationen enthaltend | |
DE102005029390A1 (de) | Wirkstoffkombinationen aus Glycopyrroniumbromid und Polyolen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20101020 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: HOELTKEMEIER, STEFANIE Inventor name: PETERS, NILS Inventor name: KNAUPMEIER, STEFANIE Inventor name: NEUFANG, GITTA Inventor name: ECKERT, JULIA Inventor name: KOLBE,LUDGER |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: PETERS, NILS Inventor name: KNAUPMEIER, STEFANIE Inventor name: NEUFANG, GITTA Inventor name: ECKERT, JULIA Inventor name: KOLBE,LUDGER |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20131108 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
APBK | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNE |
|
APBN | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2E |
|
APBR | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3E |
|
APAF | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNE |
|
APBX | Invitation to file observations in appeal sent |
Free format text: ORIGINAL CODE: EPIDOSNOBA2E |
|
APBT | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9E |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20201125 |